ANDA 40621, held by Sun Pharmaceutical Industries. Phenytoin Sodium.
As of Nov 21, 2026, ANDA 40621 (Extended Phenytoin Sodium), held by Sun Pharmaceutical Industries, was first approved by FDA on Dec 11, 2006, with 2 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 11, 2006 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Extended Phenytoin Sodium100MG EXTENDED · capsule;oral | Phenytoin Sodium | Discontinued |
| Jan 21, 2014 | Supplement 8Labeling · Standard review | Approved | None posted |
| Jan 21, 2010 | Supplement 7Labeling | Approved | None posted |
| Dec 11, 2006 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters